Webinars |
Pharmaceuticals and Drug Discovery
Pharmaceuticals and Drug Discovery Webinars
Promoted Webinars
Pharmaceuticals and Drug Discovery Webinars
The continuous monitoring concept for pharmaceutical manufacturing
Compliant documentation in the drug manufacturing process is essential. 21 CFR Part 11 compliance software helps achieve this from raw materials to finished goods. In addition, the qualifications of individual instruments benefit from software-supported functionality.
In this webinar, Dr. Huo Tong will discuss the barriers associated with CAR-NK cell production and provide solutions to improve their development process.
Handheld Raman spectrometers have fundamentally changed how the pharmaceutical industry performs incoming raw material identification.
This webcast explores the use of a portable x-ray fluorescence (XRF) instrument, the Thermo Scientific™ IonicX™, and explains how it can identify ionic salts in seconds and replace traditional time-consuming and resource-intensive wet chemistry and benchtop methods.
This webinar reviews light scattering-based methods for protein characterization and explain their utility, when combined with partially denaturing buffers, in understanding aggregation propensity of monoclonal antibodies (mAbs).
COVID-19 is a global pandemic caused by the SARS-CoV-2 virus. There is a huge worldwide effort underway to discover vaccines and new drugs, and to repurpose old drugs to treat this disease.
The expedited schemes available from global regulatory bodies offer significant advantages for drug product developers. While the basic tenants of quality, safety and efficacy testing remain, such programs have been introduced to rapidly get cutting edge treatments to target patient populations.
Antibody-Drug Conjugates (ADCs) are a rapidly growing class of oncology therapeutics wherein a potent cytotoxic drug is conjugated to the antibody molecule. The impact of drug conjugation on the antibody's conformation needs to be evaluated.
Kinetic Characterization of Covalent Inhibitors on the PHERAstar
A TR-FRET approach to measuring the kinetics of ligand-receptor binding and its application of fragment screening
Receptor function is multifaceted and it is therefore highly advantageous to monitor multiple aspects in live cells and in real-time.
Optimizing the receptor binding kinetics of new drugs can have significant benefits, including improved action duration and enhanced efficacy.
The webinar will update on latest developments in MALDI mass spectrometry for high-throughput screening and CPD profiling (rapifleX MALDI PharmaPulse) and introduce Bruker's new surface plasmon resonance (SPR) instrument, the SIERRA SPR-32.
The presentation will give a current overview of label-free high-throughput MALDI TOF mass spectrometry and its use in drug discovery screening. It will explain the basics of MALDI TOF mass spectrometry and the benefits of label-free screening compared to current labeled approaches.